Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Humanization of immunotoxins.

S M Rybak1, H R Hoogenboom, H M Meade

  • 1Biochemistry Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20896.

Proceedings of the National Academy of Sciences of the United States of America
|April 15, 1992
PubMed
Summary

Researchers created a novel antibody-enzyme fusion protein targeting the transferrin receptor. This engineered immunotoxin effectively kills cancer cells expressing the transferrin receptor, showing promise for new cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal diagnosis of portal vein thrombosis by ultrasound.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2003
Same author

A glutamate mutase is involved in the biosynthesis of the lipopeptide antibiotic friulimicin in Actinoplanes friuliensis.

Antimicrobial agents and chemotherapy·2003
Same author

The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.

Clinical nephrology·2002
Same author

In situ identification of mycobacteria in Crohn's disease patient tissue using confocal scanning laser microscopy.

Molecular and cellular probes·2002
Same author

Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation?

British journal of cancer·2002
Same author

Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002

Area of Science:

  • Immunology
  • Molecular Biology
  • Biotechnology

Background:

  • Antibody-enzyme fusions offer targeted cancer therapy potential.
  • Human transferrin receptor is a target for selective cell killing.
  • Angiogenin, a human RNase, has cytotoxic properties.

Purpose of the Study:

  • To construct and express a chimeric antibody-enzyme fusion protein.
  • To evaluate the targeted cytotoxicity of the fusion protein against tumor cells.
  • To demonstrate the feasibility of humanized immunotoxins for cancer treatment.

Main Methods:

  • Gene construction of a mouse/human chimeric antibody fused to human angiogenin.
  • Expression of the antibody-enzyme fusion protein in a transfectoma cell line.
  • Assay of fusion protein's effect on K562 cells (transferrin receptor-positive) and control cells.

Related Experiment Videos

Main Results:

  • Successfully synthesized and secreted a functional antibody-enzyme fusion protein.
  • Fusion protein inhibited growth and protein synthesis of transferrin receptor-expressing K562 cells.
  • Cytotoxicity was mediated by the transferrin receptor and the angiogenin component.

Conclusions:

  • Recombinant antibody-RNase molecules can be constructed to kill transferrin receptor-bearing tumor cells.
  • This approach demonstrates the feasibility of targeted immunotoxins.
  • Humanized immunotoxins may reduce toxicity and immunogenicity in cancer therapy.